Use of systemic corticosteroids for other indications than COVID-19 in doses higher than 6 mg dexamethasone equivalents <br/ >Use of systemic corticosteroids for COVID-19 for 5 consecutive days or more <br/ >Invasive fungal infection <br/ >ctive tuberculosis <br/ >Fertile woman ( <60 years of age) with positive urine human gonadotropin (hCG) or plasma-hCG <br/ >Known hypersensitivity to dexamethasone <br/ >Previously randomised into the COVID STEROID 2 trial <br/ >Informed consent not obtainable <br/ >

Use of systemic corticosteroids for other indications than COVID-19 in doses higher than 6 mg dexamethasone equivalents <br/ >Use of systemic corticosteroids for COVID-19 for 5 consecutive days or more <br/ >Invasive fungal infection <br/ >ctive tuberculosis <br/ >Fertile woman ( <60 years of age) with positive urine human gonadotropin (hCG) or plasma-hCG <br/ >Known hypersensitivity to dexamethasone <br/ >Previously randomised into the COVID STEROID 2 trial <br/ >Informed consent not obtainable <br/ >

N/A

N/A

Use of systemic corticosteroids for other indications than COVID-19 in doses higher than 6 mg dexamethasone equivalents <br/ >Use of systemic corticosteroids for COVID-19 for 5 consecutive days or more <br/ >Invasive fungal infection <br/ >ctive tuberculosis <br/ >Fertile woman ( <60 years of age) with positive urine human gonadotropin (hCG) or plasma-hCG <br/ >Known hypersensitivity to dexamethasone <br/ >Previously randomised into the COVID STEROID 2 trial <br/ >Informed consent not obtainable <br/ >

Use of systemic corticosteroids for other indications than COVID-19 in doses higher than 6 mg dexamethasone equivalents <br/ >Use of systemic corticosteroids for COVID-19 for 5 consecutive days or more <br/ >Invasive fungal infection <br/ >ctive tuberculosis <br/ >Fertile woman ( <60 years of age) with positive urine human gonadotropin (hCG) or plasma-hCG <br/ >Known hypersensitivity to dexamethasone <br/ >Previously randomised into the COVID STEROID 2 trial <br/ >Informed consent not obtainable <br/ >